1. Home
  2. MNKD vs DMLP Comparison

MNKD vs DMLP Comparison

Compare MNKD & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • DMLP
  • Stock Information
  • Founded
  • MNKD 1991
  • DMLP 2003
  • Country
  • MNKD United States
  • DMLP United States
  • Employees
  • MNKD N/A
  • DMLP N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • DMLP Oil & Gas Production
  • Sector
  • MNKD Health Care
  • DMLP Energy
  • Exchange
  • MNKD Nasdaq
  • DMLP Nasdaq
  • Market Cap
  • MNKD 1.8B
  • DMLP 1.6B
  • IPO Year
  • MNKD 2004
  • DMLP N/A
  • Fundamental
  • Price
  • MNKD $6.36
  • DMLP $32.90
  • Analyst Decision
  • MNKD Strong Buy
  • DMLP
  • Analyst Count
  • MNKD 5
  • DMLP 0
  • Target Price
  • MNKD $8.40
  • DMLP N/A
  • AVG Volume (30 Days)
  • MNKD 2.8M
  • DMLP 132.7K
  • Earning Date
  • MNKD 11-07-2024
  • DMLP 10-31-2024
  • Dividend Yield
  • MNKD N/A
  • DMLP 12.29%
  • EPS Growth
  • MNKD N/A
  • DMLP 4.55
  • EPS
  • MNKD 0.08
  • DMLP 2.78
  • Revenue
  • MNKD $267,200,000.00
  • DMLP $166,454,000.00
  • Revenue This Year
  • MNKD $45.36
  • DMLP N/A
  • Revenue Next Year
  • MNKD $16.99
  • DMLP N/A
  • P/E Ratio
  • MNKD $74.80
  • DMLP $11.76
  • Revenue Growth
  • MNKD 51.35
  • DMLP 14.26
  • 52 Week Low
  • MNKD $3.17
  • DMLP $28.41
  • 52 Week High
  • MNKD $7.63
  • DMLP $35.74
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 38.90
  • DMLP 45.31
  • Support Level
  • MNKD $5.81
  • DMLP $32.00
  • Resistance Level
  • MNKD $6.77
  • DMLP $34.50
  • Average True Range (ATR)
  • MNKD 0.25
  • DMLP 0.88
  • MACD
  • MNKD -0.07
  • DMLP -0.16
  • Stochastic Oscillator
  • MNKD 36.44
  • DMLP 25.66

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests

Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.

Share on Social Networks: